Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas V Guzior

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Microbiome|June 15, 2021
Review: microbial transformations of human bile acidsDouglas V Guzior, Robert A Quinn
Nature Metabolism|May 10, 2023
A multi-omic trip through the human gutRobert A Quinn, Christian Martin, Douglas V Guzior
Journal of Lipid Research|November 29, 2025
Serum cholic acid and cecal Faecalibaculum increase in a male-specific manner in a murine hepatocellular carcinoma modelAngela E Dean, Douglas V Guzior, Robert A Quinn, et al.
Frontiers in Cell and Developmental Biology|February 20, 2024
Glucocorticoid-induced osteoporosis is prevented by dietary prune in female miceNicholas J Chargo, Kerri Neugebauer, Douglas V Guzior, et al.
Frontiers in Cellular and Infection Microbiology|May 23, 2024
Shifts in the functional capacity and metabolite composition of the gut microbiome during recovery from enteric infectionZoe A Hansen, Anthony L Schilmiller, Douglas V Guzior, et al.
Frontiers in Oncology|March 6, 2026
Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growthPeter Cornelius, Benjamin A Mayes, Andrew J Dannenberg, et al.
Communications Biology|November 14, 2024
Longitudinal analyses of infants' microbiome and metabolome reveal microbes and metabolites with seemingly coordinated dynamicsHao Wu, Douglas V Guzior, Christian Martin, et al.
Nature Communications|April 10, 2025
Balance between bile acid conjugation and hydrolysis activity can alter outcomes of gut inflammationYousi Fu, Douglas V Guzior, Maxwell Okros, et al.
Cell Reports|December 15, 2021
Streptozotocin-induced hyperglycemia alters the cecal metabolome and exacerbates antibiotic-induced dysbiosisJenna I Wurster, Rachel L Peterson, Claire E Brown, et al.
Research Square|October 16, 2023
Longitudinal Microbial and Molecular Dynamics in the Cystic Fibrosis Lung after Elexacaftor-Tezacaftor-Ivacaftor therapyChristian Martin, Douglas V Guzior, Cely T Gonzalez, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Microbiome|June 15, 2021
Review: microbial transformations of human bile acidsDouglas V Guzior, Robert A Quinn
Nature Metabolism|May 10, 2023
A multi-omic trip through the human gutRobert A Quinn, Christian Martin, Douglas V Guzior
Journal of Lipid Research|November 29, 2025
Serum cholic acid and cecal Faecalibaculum increase in a male-specific manner in a murine hepatocellular carcinoma modelAngela E Dean, Douglas V Guzior, Robert A Quinn, et al.
Frontiers in Cell and Developmental Biology|February 20, 2024
Glucocorticoid-induced osteoporosis is prevented by dietary prune in female miceNicholas J Chargo, Kerri Neugebauer, Douglas V Guzior, et al.
Frontiers in Cellular and Infection Microbiology|May 23, 2024
Shifts in the functional capacity and metabolite composition of the gut microbiome during recovery from enteric infectionZoe A Hansen, Anthony L Schilmiller, Douglas V Guzior, et al.
Frontiers in Oncology|March 6, 2026
Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growthPeter Cornelius, Benjamin A Mayes, Andrew J Dannenberg, et al.
Communications Biology|November 14, 2024
Longitudinal analyses of infants' microbiome and metabolome reveal microbes and metabolites with seemingly coordinated dynamicsHao Wu, Douglas V Guzior, Christian Martin, et al.
Nature Communications|April 10, 2025
Balance between bile acid conjugation and hydrolysis activity can alter outcomes of gut inflammationYousi Fu, Douglas V Guzior, Maxwell Okros, et al.
Cell Reports|December 15, 2021
Streptozotocin-induced hyperglycemia alters the cecal metabolome and exacerbates antibiotic-induced dysbiosisJenna I Wurster, Rachel L Peterson, Claire E Brown, et al.
Research Square|October 16, 2023
Longitudinal Microbial and Molecular Dynamics in the Cystic Fibrosis Lung after Elexacaftor-Tezacaftor-Ivacaftor therapyChristian Martin, Douglas V Guzior, Cely T Gonzalez, et al.
Pageof 2